Advanced oxidation technology for the effective treatment of APIs in water and wastewater
Among the many anthropogenic micropollutants being released into the aqueous environment, the effects of active pharmaceutical ingredients (APIs), including feminisation of fish, increasing susceptibility to predation and increasing antibiotic resistance, are a growing concern. Whilst there is currently no legislation in place in the UK to cover APIs and other emerging pollutants, studies such as Chemical Investigations Programme Phase 2 (CIP2), which ran from 2015-2020, have flagged up painkillers, antibiotics and hormone contraceptives excreted by users of these medications as being of potential concern. Research assessing the effects of APIs in the UK’s aquatic environment1 found a range of APIs including Ibuprofen, diclofenac, ethinyloestradiol, clarithromycin and azithromycin in the final effluent from wastewater treatment works (WwTWs) and concluded that as many as 890 WwTWs in the UK were releasing APIs in their effluents exceeding the predicted no effect concentrations (PNEC).
Read full article Here: Water Projects Online
Article featured in Water Projects Online
About the Author: Ben Hazard
Process Engineer
Ben is an experienced process engineer with a Master’s degree in Chemical Engineering from Loughborough University. He started his career as an engineering graduate for Affinity Water and has since delivered process solutions on a range of water and wastewater treatment schemes. More recently, he has developed the water and wastewater treatment product portfolio. Find out more about Ben and some more of the Te-Tech members Here
Contact Us for more information or to talk about your requirements enquiries@te-tech.co.uk